T he US Food and Drug Administration (FDA) and pharmaceutical company Novo Nordisk are now in an attempt to making more ...

BP says investors back the new strategy of refocusing on oil and gas. But it is not hard to find scepticism over whether the ...

La obesidad se ha convertido en un serio problema de salud pública. En este oportuno ensayo, Naief Yehya nos ofrece un ...

En respuesta a las nuevas tensiones comerciales entre Estados Unidos y Europa, el grupo de lujo francés Hermès anunció que ...

The portfolio solidly beat its primary and secondary benchmarks, the MSCI EAFE Index and MSCI AC World ex USA Index, in Q1.

Redacción Nace Andala, la startup española que busca mejorar la salud intestinal y el bienestar de las personas En una sociedad donde la salud digestiva se ha convertido en una de las principales preo ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Pharmaceutical company Novo Nordisk will expand its production site in Montes Claros, Brazil, creating 600 jobs.

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of diabetes and weight loss, got another ...

Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...

Novo Nordisk A/S (NVO) is a high-quality biopharma company that has been a growth play well before its recent obesity drug hit. Shares were hyped a while ago, but have now declined so much that ...